Vir Biotechnology Inc (VIR)
Receivables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 73,109 | 78,618 | 72,140 | 56,343 | 46,679 | 51,681 | 427,211 | 397,246 | 1,580,474 | 2,368,441 | 2,099,722 | 2,316,395 | 1,087,060 | 277,605 | 175,080 | 67,363 | 67,245 | 67,315 | 67,364 | 1,181 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $73,109K ÷ $—K
= —
The receivables turnover ratio for Vir Biotechnology Inc is not available or provided in the financial data for the periods provided, from March 31, 2020, to December 31, 2024. The receivables turnover ratio is a measure of how efficiently a company is managing its accounts receivable in generating sales revenue.
Without the specific data points for receivables turnover, it is not possible to analyze or assess the effectiveness of Vir Biotechnology Inc in collecting its accounts receivable within a given period. A higher receivables turnover ratio typically indicates a more efficient collection process, while a lower ratio may suggest potential issues with collecting outstanding amounts.
In future reporting, it would be beneficial to include the receivables turnover ratio to provide insights into the company's credit and collection policies, as well as its overall liquidity and operating efficiency.
Peer comparison
Dec 31, 2024